SMYD4 Monoclonal antibody
SMYD4 Monoclonal Antibody for WB, ELISA
Host / Isotype
Mouse / IgG1
Reactivity
Human
Applications
WB, ELISA
Conjugate
Unconjugated
CloneNo.
2F4B7
验证数据展示
经过测试的应用
Positive WB detected in | MCF-7 cells |
推荐稀释比
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:1000-1:6000 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
66874-1-Ig targets SMYD4 in WB, ELISA applications and shows reactivity with Human samples.
Tested Applications | WB, ELISA Application Description |
Tested Reactivity | Human |
Immunogen | SMYD4 fusion protein Ag11552 种属同源性预测 |
Host / Isotype | Mouse / IgG1 |
Class | Monoclonal |
Type | Antibody |
Full Name | SET and MYND domain containing 4 |
Synonyms | KIAA1936, SMYD4, ZMYND21 |
Calculated Molecular Weight | 804 aa, 89 kDa |
Observed Molecular Weight | 85-89 kDa |
GenBank Accession Number | BC035077 |
Gene Symbol | SMYD4 |
Gene ID (NCBI) | 114826 |
RRID | AB_2882208 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Protein G purification |
UNIPROT ID | Q8IYR2 |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
SMYD4, also named as SET and MYND domain-containing protein 4, is a 804 amino acid protein, which contains 1 MYND-type zinc finger and 1 SET domain. SMYD4 belongs to the class V-like SAM-binding methyltransferase superfamily. SMYD4, as a potential tumor suppressor, plays a critical role in breast carcinogenesis at least partly through inhibiting the expression of Pdgfr-alpha, and could be a novel target for improving treatment of breast cancer. SMYD4 is a muscle-specific transcriptional modulator involved in development.
实验方案
Product Specific Protocols | |
---|---|
WB protocol for SMYD4 antibody 66874-1-Ig | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |